Dr. Auwaerter interviews Dr. Shmuel Shoham about clinical trial challenges in the era of COVID-19. Topics: *Regulatory, cultural and social challenges *Patient recruitment *Convalescent plasma *Multiple competing studies for inpatients *Problems with COVID+ space for outpatient research
Dr. Auwaerter interviews Dr. Shmuel Shoham about COVID-19 prophylaxis trials. Topics: *Hydroxychloroquine *Monoclonal antibodies *Convalescent plasma *Vaccine trials *Challenges of these trials
MiKaela Olsen DNP, APRN-CNS, AOCNS, FAAN discusses providing cancer care during a pandemic. Topics: *Protecting staff and patients from COVID-19 *Oncology Nursing Society guidelines for cancer care during COVID-19 *Innovative ways to deliver care *Algorithms to guide PPE use in oncology care *Treating the COVID-19+ cancer patient
Dr. Auwaerter covers the following topics: *Efficacy of cloth face coverings vs. surgical masks *Reopening schools and colleges *The role of HVAC units on COVID-19 transmission *Studies of tocilizumab and other IL-6-targeted drugs *Percent of the population that needs vaccination *Co-infection with influenza *Trial of inhaled interferon beta
Sam Matta, RN, CFRN, NRP discusses high flow nasal cannula (HFNC) and how it applies to COVID-19. Topics: *Physiological effect *HFNC and hypoxia *Aerosol risk with HFNC *Lifeline deployment *Common complications
Dr. Auwaerter covers the following topics: *Manifestations beyond the respiratory tract *Moderna vaccine phase 1 trial *Immunity for patients who’ve recovered from COVID-19 *Pool testing as a means to alleviate testing shortages and open schools and businesses *Aerosol transmission
Dr. Paul Auwaerter interviews Dr. Kathleen Page about COVID-19 public policy and research efforts. Topics: *Policy impacts on immigrants *Treatment considerations for immigrants *Including minority communities in research trials *Improving communication with minority communities
Dr. Auwaerter covers the following topics: *Recurrences of COVID-19 symptoms *Hydroxychloroquine study from Michigan *Sarilumab (anti-IL6) monoclonal antibody *Operation Warp Speed update *Differences in mortality rates among States *Nasal vs. nasopharyngeal test accuracy.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Our ability to reduce HIV infection and transmission depends on testing, in particular assessing the status of at-risk people who continue to remain untested.
In this issue, Dr. Cedric Bien-Gund from the Division of Infectious Diseases at the University of Pennsylvania takes us to the clinic to explain the pros and cons of the currently available HIV tests and explains which are best to use in particular clinical circumstances.
Dr. Auwaerter updates us on COVID-19 and answers your questions. Topics covered:Dr. Auwaerter updates us on COVID-19 and answers your questions. Topics covered:
- Advising patients on travel
- Antibody seroprevalence
- Time from exposure to positive test
- JAMA Greek colchicine study
- Using low dose radiation to combat the cytokine storm